Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine

Artificial Cells, Nanomedicine and Biotechnology

Volumn 42, Issue 1, 2014, Pages 47-57

  Mangal, Sharad ^a,b   Pawar, Dilip ^a,c   Agrawal, Udita ^a   Jain, Arvind K ^a   Vyas, Suresh P ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b MONASH UNIVERSITY   (Australia)

^c Biocon Limited   (India)

Author keywords

Alginate; Chitosan; Microparticles; Mucosal vaccination

Indexed keywords

ANTHRAX VACCINES; CHITOSAN MICROPARTICLES; IMMUNE RESPONSE; MICRO-PARTICLES; MUCOADHESIVE CARRIERS; MUCOSAL IMMUNE RESPONSE; MUCOSAL VACCINATION; PEYER'S PATCHES;

ALGINATE; CHITOSAN; DISEASES; IMMUNE SYSTEM; IMMUNIZATION;

VACCINES;

ADJUVANT; ALGINIC ACID; ALUMINUM POTASSIUM SULFATE; ANTHRAX VACCINE; CHITOSAN; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; MUCOADHESION; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; STOMACH JUICE; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ALGINATES; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BIOMIMETIC MATERIALS; CHITOSAN; FEMALE; GASTRIC JUICE; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PEYER'S PATCHES; VACCINATION;

EID: 84892733698     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2013.769447     Document Type: Article

References (32)

1. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. 1993. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 90: 2291.
2. Berthold I, Pombo ML, Wagner L, Arciniega JL. 2005. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminium adjuvants. Vaccine. 23: 1993-1999.
3. Bonferoni MC, Rossi S, Ferrari F, Caramella C. 1999. A modified cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm Dev Technol. 4: 45-53.
4. Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. 2005. Preparation of coated microparticles for a new mucosal vaccine delivery system. Int J Pharm. 299: 155-166.
5. Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee Jr. 2003. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. J Immunol. 170: 5636-5643.
6. Debin A, Kravtzoff R, Santiago JV, Cazales L, Sperandio S, Melber K, et al. 2002. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine. 20: 2752-2763.
7. Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Rice TR. 1990. Controlled vaccine release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer ' s patches. J Control Release. 11: 205-214.
8. Elson CO, Ealding W, Lefkowitz JA. 1984. Lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods. 67: 101-108.
9. Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine. 19: 3241.
10. Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. 2002. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm. 232: 225-234.
11. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. 2001. Quantitative pathology of inhalational anthrax. I. Quantitative microscopic findings. Mod Pathol. 14: 482.
12. He P, Davis SS, Illum L. 1998. In-vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 166: 75-88.
13. Ivins BE, Pitt ML, Fellows PF, Farchaus JW, Benner GE, Waag DW, et al. 1998. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine. 16: 1141.
14. Jaganathan KS, Rao YUV, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. 2005. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm. 294: 23-32.
15. Jain S, Sharma RK, Vyas SP. 2006. Chitosan microparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J Pharm Pharmacol. 58: 303-310.
16. Jain S, Singh P, Mishra V, Vyas SP. 2005. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett. 101: 41-49.
17. Lopez CR, Portero A, Lemos M, Vila-Jato JL, Nunez MJ, Riveiro P, et al. 2000. Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity. STP Pharma Sci. 10: 69-76.
18. Malik B, Goyal AK, Mangal S, Zakir F, Vyas SP. 2010. Implication of gut immunology in the design of oral vaccines. Curr Mol Med. 10: 47-70.
19. Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS, Jaganathan KS. 2011. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine. 29: 4953-4962.
20. Medina E, Guzm á n CA. 2000. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol Med Microbiol. 4: 305-311.
21. Mishra N, Goyal AK, Tiwari S, Paliwal R, Paliwal SR, Vaidya B, et al. 2010. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Th er Pat. 20: 661-679.
22. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 5: 55-63.
23. Pawar D, Goyal AK, Mangal S, Mishra N, Vaidya B, Tiwari S, et al. 2010. Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J. 12: 130-137.
24. Reuveny S, White MD, Adar YY, Altboum YKZ, Gozes Y, Kobiler D, et al. 2001. Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun. 69: 2888-2893.
25. Rossi S, Bonferoni MC, Ferrari F, Caramella C. 1999. Drug release and washability of mucoadhesive gels based on sodium carboxymethylcellulose and polyacrylic acid. Pharm Dev Technol. 4: 55-63.
26. Shimoda J, Onishi H, Machida Y. 2001. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev Ind Pharm. 27: 567-576.
27. Singh Y, Leppla SH, Bhatnagar R, Friedlander AM. 1989. Internalization and processing of Bacillus anthracis lethal toxin by toxinsensitive and resistant cells. J Biol Chem. 64: 11099-11102.
28. Smith MW, Thomas NW, Jenkins NW, Miller PG, Cremaschi NGA, Porta C. 1995. Selective transport of microparticles across peyer ' s follicle associated M cells from mice and rats. Exp Phys. 80: 735-743.
29. Welkos S, Friedlander A, Weeks S, Little S, Mendelson I. 2002. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol. 51: 821.
30. Welkos S, Little S, Friedlander A, Fritz D, Fellows P. 2001. Th e role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology. 147: 1677.
31. Williamson ED, Beedham RJ, Bennett AM, Perkins SD, Miller J, Baillie LWJ. 1999. Presentation of protective antigen to the mouse immune system: immune sequelae. J Appl Microbiol. 87: 315-317.
32. Xu Y, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 250: 215-226.